




Associations between left bundle branch block with different PR intervals, QRS
durations, heart rates and the risk of heart failure
a register-based cohort study using ECG data from the primary care setting
Søndergaard, Marc Meller; Riis, Johannes; Bodker, Karoline Willum; Hansen, Steen Møller;
Nielsen, Jesper; Graff, Claus; Pietersen, Adrian Holger; Nielsen, Jonas Bille; Tayal,











Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Søndergaard, M. M., Riis, J., Bodker, K. W., Hansen, S. M., Nielsen, J., Graff, C., Pietersen, A. H., Nielsen, J.
B., Tayal, B., Polcwiartek, C., Torp-Pedersen, C., Soegaard, P., & Kragholm, K. H. (2021). Associations between
left bundle branch block with different PR intervals, QRS durations, heart rates and the risk of heart failure: a
register-based cohort study using ECG data from the primary care setting. Open Heart, 8(1), [e001425].
https://doi.org/10.1136/openhrt-2020-001425
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Open access 
  1Søndergaard MM, et al. Open Heart 2021;8:e001425. doi:10.1136/openhrt-2020-001425
 ► Additional material is 
published online only. To view, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
openhrt- 2020- 001425).
To cite: Søndergaard MM, 
Riis J, Bodker KW, et al. 
Associations between left 
bundle branch block with 
different PR intervals, QRS 
durations, heart rates and the 
risk of heart failure: a register- 
based cohort study using ECG 
data from the primary care 
setting. Open Heart 
2021;8:e001425. doi:10.1136/
openhrt-2020-001425
Received 20 August 2020
Revised 26 November 2020
Accepted 1 December 2020
For numbered affiliations see 
end of article.
Correspondence to
Marc Meller Søndergaard;  marc- 
m- s12@ hotmail. com
Associations between left bundle 
branch block with different PR 
intervals, QRS durations, heart rates 
and the risk of heart failure: a register- 
based cohort study using ECG data from 
the primary care setting
Marc Meller Søndergaard   ,1 Johannes Riis,1 Karoline Willum Bodker,1 
Steen Møller Hansen,1 Jesper Nielsen,1 Claus Graff,2 Adrian Holger Pietersen,3 
Jonas Bille Nielsen,4,5 Bhupendar Tayal,6 Christoffer Polcwiartek,7 
Christian Torp- Pedersen,8 Peter Soegaard,9 Kristian Hay Kragholm1,10
Heart failure and cardiomyopathies
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
ABSTRACT
Aim Left bundle branch block (LBBB) is associated with 
an increased risk of heart failure (HF). We assessed the 
impact of common ECG parameters on this association 
using large- scale data.
Methods and results Using ECGs recorded in a large 
primary care population from 2001 to 2011, we identified 
HF- naive patients with a first- time LBBB ECG. We obtained 
information on sex, age, emigration, medication, diseases 
and death from Danish registries. We investigated the 
association between the PR interval, QRS duration, and 
heart rate and the risk of HF over a 2- year follow- up 
period using Cox regression analysis.
Of 2471 included patients with LBBB, 464 (18.8%) 
developed HF during follow- up. A significant interaction 
was found between QRS duration and heart rate (p<0.01), 
and the analyses were stratified on these parameters. 
Using a QRS duration <150 ms and a heart rate <70 beats 
per minute (bpm) as the reference, all groups were 
statistically significantly associated with the development 
of HF. Patients with a QRS duration ≥150 ms and heart rate 
≥70 bpm had the highest risk of developing HF (HR 3.17 
(95% CI 2.41 to 4.18, p<0.001). There was no association 
between the PR interval and HF after adjustment.
Conclusion Prolonged QRS duration and higher heart 
rate were associated with increased risk of HF among 
primary care patients with LBBB, while no association was 
observed with PR interval. Patients with LBBB with both a 
prolonged QRS duration (≥150 ms) and higher heart rate 
(≥70 bpm) have the highest risk of developing HF.
INTRODUCTION
Left bundle branch block (LBBB) has an 
estimated prevalence of 0.19%–0.82% in the 
general population, varying between studies 
and increasing with age.1 2 LBBB is known 
to be associated with an increased risk of 
cardiovascular disease, including heart failure 
(HF) and long- term mortality.3–9 Patients 
with LBBB have an abnormal electrical acti-
vation due to conduction block resulting into 
delayed activation of the left ventricular (LV) 
free wall.10 This abnormal activation gradually 
leads to an inefficient contraction pattern with 
subsequent development of HF.10 However, 
since not all patients with LBBB develop HF, 
there must be other underlying associated 
pathophysiological and electrical factors which 
are playing a critical role in the eventual devel-
opment of HF.
LBBB is a diagnosis which can be made 
with routine ECG recordings, thus identifi-
cation of other common ECG parameters 
which can help in further risk stratification of 
these patients is important.
Key questions
What is already known about this subject?
 ► It has been established that left bundle branch block 
is associated with an increased risk of heart failure. 
However, the underlying mechanisms are not fully 
understood.
What does this study add?
 ► We showed that patients with a longer QRS duration 
and higher heart rate have a higher risk of heart fail-
ure. We also showed that the PR interval was unre-
lated to heart failure.
How might this impact on clinical practice?
 ► Special attention should be paid to patients present-
ing with a longer QRS duration and higher heart rate 
in the primary care setting.
by copyright.
 on F















2 Søndergaard MM, et al. Open Heart 2021;8:e001425. doi:10.1136/openhrt-2020-001425
Several studies of prognostic ECG markers in LBBB indi-
cate that the duration of the QRS complex in patients with 
LBBB increases risk of developing HF,6 8 11 as it results in 
abnormal filling time of the ventricle.12 But the width of the 
QRS complex, in combination with other ECG parameters, 
has not been thoroughly examined. Two interesting param-
eters in this context are the PR interval and heart rate. 
Theoretically, a longer PR interval results in atrioventric-
ular asynchrony impacting the ventricle filling which may 
result in HF, but it is not known if the PR interval affects the 
outcome in patients with LBBB.13 Similarly, an increase in 
heart rate decreases the ventricular filling time. Moreover, 
reflex tachycardia is observed in patients with deteriorating 
left ventricle function and HF, and could therefore be a 
marker of the beginning of HF.14
We hypothesised that heart rate and QRS duration, 
as well as the PR interval in patients with LBBB, may 
be important risk markers that can optimise risk strati-
fication and facilitate appropriate referral to secondary 
specialised cardiology evaluation and treatment. To inves-
tigate this, we identified primary care ECGs with LBBB 
and assessed the association between the heart rate and 
QRS duration as well as PR interval and the development 
of HF.
METHODS
Study setting and population
We studied 12- lead ECGs recorded between January 2001 
and September 2011 at the Copenhagen General Practi-
tioners Laboratory, a centralised core facility offering para-
clinical examinations including high- quality and stand-
ardised digital ECG procedures in patients referred from 
general practitioners in the capital region of Copenhagen, 
Denmark, which represents around 30% of the Danish 
population.
First, we identified all patients with LBBB using the 
validated Marquette 12SL algorithm, V.21 (online supple-
mental material 1).15 16 We included patients at the time 
of their first ECG recording showing LBBB, as done 
previously.17
From the included patients with LBBB, we excluded 
those with missing date of birth, ECGs of poor quality, 
implanted cardiac devices, certain arrhythmias and known 
HF (online supplemental table 2). Patients with the 
following arrhythmias were excluded: pace rhythm, atrial 
fibrillation, atrial flutter, Wolf- Parkinson- White, or second 
or third degree atrioventricular block. Patients with a PR 
interval <120 ms or ≥400 ms were excluded to ensure that 
patients did not have undetected arrhythmias. Patients with 
a heart rate ≥100 beats per minute (bpm) were excluded 
as we suspected that they might have undiagnosed atrial 
fibrillation.
Lastly, we excluded patients with prior HF diagnosis 
and patients treated with loop diuretics in two consecu-
tive calendar quarters prior to LBBB diagnosis (online 
supplemental table 2).
Data sources, study variables and definitions
From the ECG recordings, we retrieved QRS duration, 
heart rate and PR interval. Participants were divided into 
groups based on clinical cut- offs described in the literature; 
that is, 150 ms for QRS duration and 200 ms for PR interval 
as the definition of first degree heart block.18 For heart 
rate within the normal reference range, participants were 
divided by the median rounded to nearest decile.
In addition to ECGs, we included patient demographics 
and clinical characteristics by linkage to a number of nation-
wide registries. All individuals with permanent residence in 
Denmark are given a unique Central Personal Registration 
number, which can be used to match data across registries. 
For a detailed description of registries used, please refer to 
the online supplemental material 1.
Outcome measures
Patients were followed for 2 years or until first HF event 
including fatal HF, death from other cause, emigration 
or end of study period on the 31st of December 2012, 
whichever came first. The primary study endpoint was the 
development of HF.
HF was defined as either a hospital admission, outpatient 
contact, an emergency room contact with an HF diagnosis 
or death from HF as done previously (online supplemental 
table 2). The HF diagnosis has previously been shown 
to have a sensitivity of 29% and specificity of 99%.19 To 
increase sensitivity, the use of loop diuretics was added, as 
done previously (online supplemental table 2).19–21 The 
10th revision of the International Statistical Classification 
of Diseases and Related Health Problems (ICD-10) codes 
for identifying HF are summarised by Schmidt et al.22
Covariates
The following comorbidities within 5 years prior to the 
first ECG showing LBBB were included: previous acute 
myocardial infarction, chronic ischaemic heart disease, 
valvular heart disease, pericardial disease, endocarditis, 
myocarditis, peripheral vascular disease, cerebrovascular 
disease, chronic lung disease, renal disease, chronic liver 
disease, malignant neoplasia, hypertension and diabetes 
(see online supplemental table 3 for ICD-10 codes).
Diabetes was identified by ICD-10 codes or treatment 
with glucose lowering drugs for diabetes or treatment with 
antihypertensive drugs for hypertension, as done previ-
ously.22 23
Baseline medication was defined as dispensed prescrip-
tions within 180 days prior to inclusion and consisted 
of cardiac glycosides, beta- blockers, ACE inhibitors and 
aldosterone antagonists (online supplemental table 3).24
Statistical analysis
Continuous variables were described using means and 
SDs when normally distributed, and median with 1st and 
3rd quartiles (Q1–Q3) when not. Normality of contin-
uous variables was checked by visual inspection of histo-
grams. Categorical variables were described using counts 
and percentages. Accordingly, Wilcoxon Mann- Whitney 
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(two groups) or Kruskal- Wallis (more than two groups) 
and Pearson’s Χ2 tests were used to test for differences 
across exposure groups.
Aalen- Johansson cumulative incidence plots were 
made to assess the development of HF according to the 
different risk groups with death as a competing risk.
Univariate and multivariable Cox proportional hazards 
regressions were used to assess associations between QRS, 
PR and heart rate groups and the risk of developing HF.
Interaction analysis between exposures and all covari-
ates were performed considering a p value of <0.01 in a 
likelihood ratio test as statistically significant. In the case 
Figure 1 Patient selection flow chart. Selection of the study population. bpm, beats per minute; CGPL, Copenhagen General 
Practitioners Laboratory; HF, heart failure; LBBB, left bundle branch block.
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of an interaction, stratification was applied using clini-
cally relevant cut- offs.
The analyses for QRS groups were adjusted for age 
(quartiles), sex, heart rate (<70 bpm and ≥70 bpm), PR 
interval (<150 bpm and ≥150 bpm), beta- blocker, hyper-
tension, diabetes, previous acute myocardial infarction, 
chronic ischaemic heart disease and renal disease.
The analyses for the PR groups were adjusted for age 
(quartiles), sex, QRS duration, heart rate, beta- blocker, 
cardiac glycosides and calcium channel blockers.
In sensitivity analyses, we performed the same analyses 
with a combined endpoint of HF and death from other 
causes.
The proportional hazard assumptions were tested 
graphically using Schoenfeld residuals. Continuous rela-
tionships between the PR interval, QRS duration and HF 
were visualised using restricted cubic with three knots 
located at the 10th, 50th and 90th percentiles. These 
analyses were adjusted for the same covariates as the Cox 
regression analyses.
In all analyses, a p value of <0.05 was considered statis-
tically significant.
Data management was performed using SAS, V.9.4 
(SAS Institute), and statistical analysis was performed 




A total of 2471 patients were included in the study 
(figure 1), of whom 464 (18.8%) developed HF while 142 
(5.7%) died during follow- up (table 1). The population 
was predominantly women (61.1%) and the median age 
was 72.2, 36.3% had hypertension and 7.5% had diabetes 
at baseline (table 1).
QRS duration and heart rate groups
Analyses revealed a significant interaction between the 
QRS groups and heart rate (p<0.01). Therefore, results 
for QRS duration and heart rate are only reported for 
stratified groups. Four subgroups were defined: (1) low 
heart rate and narrow QRS complex (<70 bpm,<150 ms, 
n=686), (2) high heart rate and narrow QRS complex 
(≥70 bpm, <150 ms, n=900), (3) low heart rate and wide 
QRS complex (<70 bpm, ≥150 ms, n=465) and (4) high 
heart rate and wide QRS complex (≥70 bpm, ≥150 ms, 
n=420).
Table 1 Characteristics of the population according to QRS duration and heart rate
Variable
QRS <150 ms+
heart rate <70 bpm 
(n=686)
QRS <150 ms+
heart rate ≥70 bpm
(n=900)
QRS ≥150 ms+
heart rate <70 bpm
(n=465)
QRS ≥150 ms+
heart rate ≥70 bpm 
(n=420) P value
Age, median, Q1–Q3 72.2 (62.8–80.8) 74.4 (64.7–82.1) 70.3 (60.4–78.5) 70 (61.1–78.6) <0.0001
Male sex, no (%) 214 (31.2) 203 (22.6) 309 (66.5) 235 (56.0) <0.001
Hypertension, no (%) 269 (39.2) 282 (31.3) 190 (40.9) 157 (37.4) <0.001
Diabetes, no (%) 36 (5.2) 66 (7.3) 39 (8.4) 44 (10.5) 0.01
MI, no (%) 11 (1.6) 8 (0.9) 8 (1.7) <4 (0.31)
IHD w/o MI, no (%) 45 (6.6) 43 (4.8) 38 (8.2) 29 (6.9) 0.08
Malignancy, no (%) 42 (6.1) 58 (6.4) 23 (4.9) 12 (2.9) 0.05
PVD, no (%) 10 (1.5) 16 (1.8) 10 (2.2) 11 (2.6) 0.55
CVD, no (%) 29 (4.2) 34 (3.8) 23 (4.9) 18 (4.3) 0.79
CLD, no (%) 19 (2.8) 23 (2.6) 4 (0.9) 11 (2.6) 0.14
Liver disease, no (%) <4 <4 <4 <4 0.54
Renal disease, no (%) <4 <4 <4 <4 0.54
Cardiac glycosides, no (%) 8 (1.2) 10 (1.1) 4 (0.9) 4 (1.0) 0.96
ACE inhibitors, no (%) 137 (20.0) 83 (9.2) 101 (21.7) 48 (11.4) 0.29
Class II anti- arrythmic 8 (1.2) 5 (0.6) 3 (0.6) 6 (1.4) <0.001
AA, no (%) 8 (1.2) 5 (0.6) <4 6 (1.4) 0.33
Outcome (heart failure), no (%) 36 (5.2) 52 (5.8) 30 (6.5) 24 (5.7)
Outcome (death), no (%) 72.2 (62.8–80.8) 74.4 (64.7–82.1) 70.3 (60.4–78.5) 70 (61.1–78.6) <0.001
Data show characteristics according to QRS duration and heart rate. Subgroup 1: QRS duration <150 ms and heart rate <70 bpm. 
Subgroup 2: QRS duration <150 ms and heart rate ≥70 bpm. Subgroup 3: QRS duration ≥150 ms and heart rate <70 bpm. Subgroup 
4: QRS duration ≥150 ms and heart rate ≥70 bpm. Categorical variables are presented with numbers and percentages and continuous 
variables with medians and 25%–75% percentiles (1st–3rd quartiles, Q1–Q3).
AA, aldosterone antagonist; bpm, beats per minute; CLD, chronic lung disease; CVD, cerebrovascular disease; MI, myocardial 
infarction; IHD w/o MI, ischaemic heart disease without myocardial infarction; PVD, peripheral vascular disease.
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Patients’ baseline characteristics according to these 
subgroups are shown in table 1.
Risk of HF based on QRS duration and heart rate
Approximately 33% of patients with a QRS duration 
of ≥150 ms and a heart rate of ≥70 bpm developed HF 
within 2 years compared with approximately 12%–18% in 
the other subgroups (figure 2A, table 1). When compared 
with the subgroup with a QRS duration <150 and heart 
rate <70, adjusted Cox regression analyses showed that 
all remaining subgroups had a significantly higher HR of 
HF (figure 3). The group with a QRS duration ≥150 and a 
heart rate ≥70 bpm had the highest HR 3.14 (95% CI 2.38 
to 4.13, p<0.001).
Analyses of QRS duration as a continuous variable strat-
ified by heart rate (<70 bpm and ≥70 bpm) using restricted 
cubic splines showed increasing hazard for HF along with 
increasing QRS duration, with a steeper incline among 
those with a heart rate ≥70 bpm (figure 4A,B).
Cumulative incidence and risk of HF by PR interval
Patients’ baseline characteristics according to PR 
subgroups are shown in online supplemental table 4. 
Patients with a PR interval ≥200 ms were older (76.0 vs 
71.3) and more likely to be men (59.5% vs 34.9%), have 
hypertension (47.5% vs 34.2%) and diabetes (9.8% vs 
7.0%). The incidence of HF was highest in the group 
with a PR interval ≥200 ms where approximately 24% 
of the patients with LBBB developed HF within 2 years 
compared with a PR interval <200 ms where approxi-
mately 18% of the patients with LBBB developed HF 
within 2 years (figure 2B, online supplemental table 4).
A PR interval of ≥200 ms was associated with an HR 
of 1.40 (95% CI 1.15 to 1.80, p<0.01) compared with a 
reference PR interval of <200 ms in unadjusted Cox anal-
ysis (figure 5). After adjustment, this association was no 
longer significant (HR of 1.16 (95% CI 0.92 to 1.46), 
p=0.225) (figure 5).
Modelling the PR interval as a continuous variable 
using restricted cubic splines showed no significant 
Figure 2 Cumulative incidence of heart failure by QRS 
duration and heart rate and by PR interval. Cumulative 
incidence of heart failure in patients with LBBB (A) with (1) 
QRS duration <150 ms and heart rate <70 bpm (black line), 
(2) QRS duration <150 ms and heart rate ≥70 bpm (blue line), 
(3) QRS duration ≥150 ms and heart rate <70 bpm (green 
line), and (4) QRS duration ≥150 ms and heart rate ≥70 bpm 
(red line); and (B) patients with PR interval <200 ms (blue line) 
and with PR interval ≥200 ms (red line). Solid lines represent 
heart failure. Dotted lines represent death from other causes. 
bpm, beats per minute; LBBB, left bundle branch block.
Figure 3 Risk of heart failure by QRS duration and heart rate. Multivariable Cox regressions showing HRs with 95% CI of 
associations between heart failure in patients with LBBB within four subgroups: (1) QRS duration <150 ms and heart rate 
<70 bpm, (2) QRS duration <150 ms and heart rate ≥70 bpm, (3) QRS duration ≥150 ms and heart rate <70 bpm, and (4) QRS 
duration ≥150 ms and heart rate ≥70 bpm. Adjusted for age groups, sex, hypertension, diabetes, previous acute myocardial 
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increase in HR for HF with increasing PR interval (online 
supplemental figure 1).
We observed no significant interactions between the 
PR groups and other covariates.
Additional analyses
Sensitivity analysis with HF and death as a combined 
endpoint revealed no notably changes of results in 
neither the QRS and heart rate subgroups nor the PR 
subgroups (online supplemental figures 2 and 3). Anal-
yses with HF without the use of loop diuretics did not 
substantially alter results (online supplemental figures 4 
and 5).
We stratified QRS and heart rate groups on the PR 
interval groups in multivariate analysis. These analyses 
revealed no statistically significant association with HF in 
any subgroup (data not shown).
Interaction analyses showed no significant interaction 
between any exposure and ischaemic heart disease, both 
with and without myocardial infarction.
DISCUSSION
Our study was based on a large number of patients with 
LBBB from the primary care sector. We found an interac-
tion between QRS duration and heart rate on the risk of 
HF. The highest risk of HF was observed among subjects 
with a QRS duration ≥150 ms and a heart rate ≥70 bpm. 
No association between PR interval and the risk of HF was 
found. These findings from primary care setting ECGs 
hold potential for risk stratification and referral practice 
to secondary cardiology evaluation and care in patients 
with LBBB.
Many patients with LBBB are prone to dyssynchronous 
contraction due to prolonged activation time in pres-
ence of bundle block. A simultaneous increase in QRS 
duration will further accentuate this dyssynchronous, 
accelerating the impairment in LV systolic function and 
decline in LV ejection fraction,12 which in turn would 
cause the cardiovascular system to compensate. Compen-
satory mechanisms include a variety of factors, such as 
increased inotropic and chronotropic responses in order 
to increase the cardiac output.14 However, the persistent 
maintenance of the cardiac output creates a greater strain 
on the myocardium and promotes remodelling, which 
Figure 4 Association between QRS duration and the risk 
of heart failure by heart rate. Restricted cubic splines with 
three knots at 10th, 50th and 90th percentiles showing the 
association between QRS duration (continuous) and the risk 
of heart failure represented by HR and stratified by (A) heart 
rate <70 bpm and (B) heart rate ≥70 bpm. Grey area indicates 
95% CI. The reference values of 150 ms was used. The 
distribution of patients is represented by blue bars. Adjusted 
for age groups, sex, hypertension, diabetes, previous acute 
myocardial infarction, chronic ischaemic heart disease, renal 
disease, beta- blockers and PR groups. bpm, beats per 
minute.
Figure 5 Risk of heart failure by PR interval. Multivariable Cox showing HRs with 95% CI of associations between heart 
failure in patients with LBBB with PR interval <200 ms and ≥200 ms, respectively. Adjusted for age groups, sex, beta- blockers, 
cardiac glycosides, calcium channel blockers and heart rate groups. LBBB, left bundle branch block.
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in turn deteriorates cardiac function.14 This duality of 
compensation and strain might explain the higher risk of 
HF in the groups with a heart rate ≥70 bpm. Our results 
are found in spite of the exclusion of patients with heart 
rate above 100 bpm, indicating that patients with LBBB 
with a higher heart rate, yet still in the normal range, 
should receive clinical attention.
We found no association between longer PR interval 
and HF in our study, implying that the PR interval holds 
no additional value in terms of HF risk in patients with 
LBBB. Similar results have been found by Aro et al,25 who 
found no increased risk of mortality or hospitalisation due 
to coronary artery disease, HF, atrial fibrillation or stroke 
with prolonged PR interval, and by Schneider et al,13 who 
in the Framingham Study, found that the PR interval in 
LBBB did not correlate with cardiovascular abnormali-
ties. Similarly, Crisel et al26 in the Heart and Soul Study 
found that first degree atrioventricular block was associ-
ated with increased risk of HF and mortality in patients 
with stable coronary artery disease. We hypothesised that 
since increased QRS duration may result in abnormal 
filling time of the ventricle, patients with prolonged QRS 
could be even more dependent on normal conduction 
from the sinus node to the ventricles. However, we did 
not observe any increased risk of HF with increased PR 
interval in patients with LBBB.
Finally, we found increased risk of HF with longer 
QRS duration, supporting previous findings. Dhingra et 
al found that increase in QRS duration was associated 
with increased risk of HF in patients with bundle branch 
block.8 Similarly, Zhang et al, in the Women’s Health 
Initiative Study, found increased risk of HF with QRS 
duration 120–139 ms and even higher risk with QRS dura-
tion ≥140 ms in patients with LBBB.6 Likewise, Zhang et 
al found increased risk of HF in patients with ventric-
ular conduction defects and QRS duration 120–139 ms 
and even higher risk with QRS duration ≥140 ms, when 
compared with no ventricular conduction defects (QRS 
<100 ms).11
Our results are similar to previous findings, showing 
that increasing QRS duration increases risk of HF. Our 
results also indicate that there are differences in the risk 
of HF within the group with LBBB according to QRS dura-
tion. Thus, our results support earlier studies regarding 
the importance of QRS duration in LBBB, but in addi-
tion, we present a new important parameter: heart rate. 
From our results, it is seen that prolonged QRS duration 
affects the myocardium differently in patients with LBBB 
. Hence, heart rate might be seen as a marker for the 
degree to which the myocardium has been affected by the 
prolonged QRS duration. QRS duration and heart rate, 
which are readily available from an ECG in the primary 
care setting where echocardiography and measurements 
of ejection fraction are not, are proposed as parameters 
for risk stratification of patients with LBBB.
Future studies should try to assess and confirm this 
interaction in regard to treatment, especially cardiac 
resynchronisation therapy in this group of patients.
Limitations
Even though our study is observational, the findings 
throughout were quite consistent. Despite our access to 
a large amount of data through Danish registries, some 
data are not recorded in these registries and were unavail-
able for use in this study. These include symptoms (New 
York Heart Association classification) and general prac-
titioners’ diagnoses, as well as clinical data such as echo-
cardiographic data including LV ejection fraction, to 
confirm systolic functional impairment before, after and 
at the time of HF diagnosis, which are all important prog-
nostic factors. Furthermore, we did not have information 
on indications for the ECG recordings. ECG screening 
of patients with no symptoms is not recommended.27 28 
However, ECG recordings are widely used in the primary 
care sector as part of many routine examinations and one 
could argue that the population of this study probably is 
representative of patients with LBBB found by chance on 
primary care ECG recordings.
Newer, stricter criteria for LBBB proposed by Strauss et 
al29 were not available for analyses.
Our results are focused on the length of the QRS 
complex in patients with LBBB only, whereas other 
studies also include other ventricular conduction defects.
CONCLUSION
In patients with LBBB seen in the primary care sector, 
a longer QRS duration combined with a higher heart 
rate is associated with increased incidence and risk of HF 
compared with patients with less prolonged QRS dura-
tion. The length of the PR interval was not associated 
with increased risk of HF in patients with LBBB.
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